National Institute of Mental Health; Notice of Closed Meeting, 35309 [2021-14222]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
biology, computational toxicology,
neurotoxicology, genetic toxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
The BSC usually meets periodically.
The authority for the BSC is provided by
42 U.S.C. 217a, section 222 of the Public
Health Service Act (PHS), as amended.
The BSC is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C.
app.), which sets forth standards for the
formation and use of advisory
committees.
[FR Doc. 2021–14222 Filed 7–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2020–0016]
Dated: June 29, 2021.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
Meetings To Implement Pandemic
Response Voluntary Agreement Under
Section 708 of the Defense Production
Act
[FR Doc. 2021–14238 Filed 7–1–21; 8:45 am]
AGENCY:
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Announcement of meetings.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; From
Genomic Association to Causation: A
Convergent Neuroscience Approach for
Neuropsychiatric Disorders (U19).
Date: July 28, 2021.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: David W. Miller, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd, Room 6140, MSC 9608,
Bethesda, MD 20892–9608, 301–443–9734,
millerda@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
The Federal Emergency
Management Agency (FEMA) is holding
a series of meetings to implement the
Voluntary Agreement for the
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic.
DATES: The schedule for these meetings
is as follows:
• The first meeting took place on
Tuesday, June 22, 2021, from 2 to 4 p.m.
Eastern Time (ET).
• The second meeting took place on
Wednesday, June 23, 2021, from 11 a.m.
to 1 p.m. ET.
• The third meeting took place on
Tuesday, June 29, 2021, from 2 to 4 p.m.
ET.
• The fourth meeting took place on
Thursday, July 1, 2021, from 2 to 4 p.m.
ET.
• The fifth meeting will take place on
Tuesday, July 20, 2021, from 11 a.m. to
1 p.m. ET.
• The sixth meeting will take place
on Thursday, July 22, 2021, from 2 to 4
p.m. ET.
• The seventh meeting will take place
on Tuesday, August 3, 2021, from 11
a.m. to 1 p.m. ET.
• The eighth meeting will take place
on Thursday, August 5, 2021, from 2 to
4 p.m. ET.
FOR FURTHER INFORMATION CONTACT:
Robert Glenn, Office of Business,
Industry, Infrastructure Integration, via
email at OB3I@fema.dhs.gov or via
phone at (202) 212–1666.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is provided as required
by section 708(h)(8) of the Defense
Production Act (DPA), 50 U.S.C.
4558(h)(8), and consistent with 44 CFR
part 332.
SUMMARY:
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
Dated: June 29, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
35309
The DPA authorizes the making of
‘‘voluntary agreements and plans of
action’’ with representatives of industry,
business, and other interests to help
provide for the national defense.1 The
President’s authority to facilitate
voluntary agreements with respect to
responding to the spread of COVID–19
within the United States was delegated
to the Secretary of Homeland Security
in Executive Order 13911.2 The
Secretary of Homeland Security further
delegated this authority to the FEMA
Administrator.3
On August 17, 2020, after the
appropriate consultations with the
Attorney General and the Chairman of
the Federal Trade Commission, FEMA
completed and published in the Federal
Register a ‘‘Voluntary Agreement,
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic’’ (Voluntary
Agreement).4 Unless terminated earlier,
the Voluntary Agreement is effective
until August 17, 2025, and may be
extended subject to additional approval
by the Attorney General after
consultation with the Chairman of the
Federal Trade Commission. The
Agreement may be used to prepare for
or respond to any pandemic, including
COVID–19, during that time.
On December 7, 2020, the first plan of
action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Personal Protective
Equipment (PPE) to Respond to COVID–
19 (PPE Plan of Action)—was finalized.5
The PPE Plan of Action established
several sub-committees under the
Voluntary Agreement, focusing on
different aspects of the PPE Plan of
Action.
On May 24, 2021, four additional
plans of action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Diagnostic Test Kits and
other Testing Components to respond to
COVID–19, the Plan of Action to
1 50
U.S.C. 4558(c)(1).
FR 18403 (Apr. 1, 2020).
3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020);
DHS Delegation Number 09052 Rev. 00 (Jan. 3,
2017).
4 85 FR 50035 (Aug. 17, 2020). The Attorney
General, in consultation with the Chairman of the
Federal Trade Commission, made the required
finding that the purpose of the voluntary agreement
may not reasonably be achieved through an
agreement having less anticompetitive effects or
without any voluntary agreement and published the
finding in the Federal Register on the same day. 85
FR 50049 (Aug. 17, 2020).
5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR
79020 (Dec. 8, 2020).
2 85
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Page 35309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14222]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; From Genomic Association to Causation: A Convergent
Neuroscience Approach for Neuropsychiatric Disorders (U19).
Date: July 28, 2021.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: David W. Miller, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room
6140, MSC 9608, Bethesda, MD 20892-9608, 301-443-9734,
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: June 29, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-14222 Filed 7-1-21; 8:45 am]
BILLING CODE 4140-01-P
